🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Distrik Columbia › Washington

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Washington, DC

4 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Ap rekriteFaz 3
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • The George Washington Medical Faculty Associates, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

Blue Light Cystoscopy With Cysview® Registry

Ap rekriteEtid obsèvasyon
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

Ap rekriteEtid obsèvasyon
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Nov 18, 2025 · NCT05672615

Etid Kansè Vezik ki pa envazif miskilè nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.